Login Register Cart 0
Generic placeholder image

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Editorial: Multi Target - Directed Ligands in the Treatment of Alzheimer’s Disease

Author(s): Ondrej Soukup and Jan Korabecny

Volume 16, Issue 9, 2019

Page: [771 - 771] Pages: 1

DOI: 10.2174/156720501609191029115310

Next »
[1]
Mezeiova E, Chalupova K, Nepovimova E, Gorecki L, Prchal L, Malinak D, et al. Donepezil derivatives targeting amyloid-β cascade in Alzheimer’s disease. Curr Alzheimer Res 16(9): 772-800. (2019).
[2]
Knez D, Sosič I, Pišlar A, Mitrović A, Jukič M, Kos J, et al. Biological evaluation of 8-hydroxyquinolines as multi-target directed ligands for treating Alzheimer’s disease. Curr Alzheimer Res 16(9): 801-14. (2019).
[3]
Malek R, Refouvelet B, Benchekroun M, Iriepa I, Andrys IMR, Musilek K, et al. Synthesis and biological evaluation of novel chromone+donepezil hybrids for Alzheimer’s disease therapy. Curr Alzheimer Res 16(9): 815-20. (2019).
[4]
Kaniakova M, Nepovimova E, Kleteckova L, Skrenkova K, Holubova K, Chrienova Z, et al. Combination of memantine and 6-chlorotacrine as novel multi-target compound against Alzheimer’s disease. Curr Alzheimer Res 16(9): 821-33. (2019).

Rights & Permissions Print Cite
Article Metrics
26
3
© 2024 Bentham Science Publishers | Privacy Policy